Search
PHARMAURACIL 250 MG / 10 ML, Solution injectable IV
Details
| --- | Description |
|---|---|
| Pack | Boîte unitaire |
| Strength (Dosage) | 250 MG / 10 ML |
| Laboratory | NOVOPHARMA |
| Ingredients | Fluorouracile |
| Therapeutic class | Antimétabolites (Antinéoplasique et immunomodulateurs) |
| ATC code | L01BC02 |
| PPH | $1.69 |
| PPV | $2.70 |
| Refundable | Yes |
| Refund base | $2.70 |
| Refund rate | $0.00 |
| Table | A |
| Marketing status | Commercialized |
| Type | Medication |
| Uses | - adénocarcinomes digestifs évolués, - cancers colorectaux après résection en situation adjuvante, - adénocarcinomes mammaires après traitement locorégional ou lors des rechutes, - adénocarcinomes ovariens, - carcinomes épidermoïdes des voies aérodigestives supérieures et œsophagiennes. |
| Warnings | |
| Dosage | |
| Avoid | |
| Side effects | |
| Interactions |
Medications from the same laboratory
Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
Report a problem